HSIC · Henry Schein, Inc.
$73.942026-05-17Sector: Healthcare; Industry: Medical - Distribution; Sub-Industry: Health Care Distributors
Intrinsic Value Range Comparison · Mulya.ai
Base · active
$22
-69.9% vs market
Mulya.ai vs Analyst IV Comparison?
Mulya.ai IV range ($22 · $36) Analysts Range ($81 · $100) Fundamentals · historical + forward · baseitalics = DCF projection
| Period | Revenue | Rev Gr ? | Ops M% ? | Tax Rate ? | NOPAT ? | Reinvest ? | FCFF ? | WACC% ? | PV FCFF ? | ROIC ? | Inv. Cap ? | EPS ? | P/E |
|---|
| 2021.Q4 | $12.4B | — | 6.9% | 23.2% | $656MM | −$730MM | −$74MM | 6.5% | — | 15.4% | $4.3B | $5.27 | — |
| 2022.Q4 | $12.6B | 2.0% | 7.4% | 23.1% | $721MM | −$192MM | $529MM | 7.6% | — | 16.4% | $4.6B | $4.55 | — |
| 2023.Q4 | $12.3B | -2.4% | 5.8% | 21.6% | $560MM | −$403MM | $157MM | 7.3% | — | 10.7% | $5.9B | $3.52 | — |
| 2024.Q4 | $12.7B | 2.7% | 5.8% | 24.3% | $552MM | −$225MM | $327MM | 7.9% | — | 9.4% | $5.9B | $3.30 | — |
| 2025.Q4 | $13.2B | 4.0% | 5.8% | 23.1% | $591MM | −$91MM | $500MM | 7.9% | — | 9.5% | $6.5B | $3.36 | 11.4 |
| italics below = DCF projection · 10yr Rev CAGR: 4.1% |
| 2026.Q4 | $13.7B | +4.1% | 5.8% | 22.8% | $613MM | −$174MM | $440MM | 8.1% | $407MM | 9.3% | $6.7B | $5.18 | 14.3 |
| 2027.Q4 | $14.3B | +4.1% | 6.2% | 22.5% | $687MM | −$187MM | $500MM | 8.1% | $428MM | 10.1% | $6.9B | $5.80 | 12.7 |
| 2028.Q4 | $14.9B | +4.1% | 6.5% | 22.2% | $747MM | −$202MM | $545MM | 8.2% | $431MM | 10.7% | $7.1B | $6.31 | 11.7 |
| 2029.Q4 | $15.5B | +4.1% | 6.5% | 21.9% | $781MM | −$218MM | $563MM | 8.2% | $411MM | 10.8% | $7.3B | $6.59 | 11.2 |
| 2030.Q4 | $16.1B | +4.1% | 6.5% | 21.6% | $815MM | −$235MM | $580MM | 8.3% | $392MM | 11.0% | $7.5B | $6.89 | 10.7 |
|
| Term. Yr+ | $20.5B | 4.1% | 3.2% | 20.0% | $529MM | −$252MM | $277MM | 8.6% | $2.8B | 8.6% | — | — | — |
Active scenario IV: $22 (-69.9% vs market)